New England Research & Management Raised Astrazeneca (AZN) Stake By $318,681; Last Week Canaccord Genuity Group Inc. (TSE:CF) Analysts

February 15, 2018 - By Kurt Siggers

Among 4 analysts covering Canaccord Financial Inc. (TSE:CF), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Canaccord Financial Inc. had 17 analyst reports since October 23, 2015 according to SRatingsIntel. The company was maintained on Friday, June 3 by Scotia Capital. The firm earned “Hold” rating on Tuesday, February 9 by TD Securities. The stock of Canaccord Genuity Group Inc. (TSE:CF) has “Sector Perform” rating given on Thursday, March 30 by Scotia Capital. TD Securities upgraded the stock to “Buy” rating in Monday, June 5 report. National Bank Canada maintained Canaccord Genuity Group Inc. (TSE:CF) on Friday, November 6 with “Sector Perform” rating. As per Wednesday, November 2, the company rating was maintained by Scotia Capital. The stock of Canaccord Genuity Group Inc. (TSE:CF) earned “Outperform” rating by National Bank Canada on Friday, May 6. The firm has “Outperform” rating by Scotia Capital given on Friday, February 10. See Canaccord Genuity Group Inc. (TSE:CF) latest ratings:

New England Research & Management Inc increased Astrazeneca (AZN) stake by 135.06% reported in 2017Q3 SEC filing. New England Research & Management Inc acquired 9,657 shares as Astrazeneca (AZN)’s stock rose 16.26%. The New England Research & Management Inc holds 16,807 shares with $569,000 value, up from 7,150 last quarter. Astrazeneca now has $78.88B valuation. The stock increased 0.63% or $0.21 during the last trading session, reaching $33.7. About 919,960 shares traded. AstraZeneca PLC (NYSE:AZN) has risen 19.45% since February 15, 2017 and is uptrending. It has outperformed by 2.75% the S&P500.

Among 26 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 16 have Buy rating, 0 Sell and 10 Hold. Therefore 62% are positive. AstraZeneca plc (ADR) had 44 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Top Pick” rating by Oddo & Cie given on Tuesday, January 26. The stock has “Equal-Weight” rating by Morgan Stanley on Friday, July 28. The stock has “Hold” rating by Cowen & Co on Monday, October 16. The rating was upgraded by Bernstein on Friday, September 22 to “Outperform”. The stock of AstraZeneca PLC (NYSE:AZN) has “Hold” rating given on Thursday, July 27 by Cowen & Co. The company was initiated on Friday, September 23 by Piperjaffray. The rating was upgraded by Credit Suisse to “Buy” on Monday, October 16. The company was downgraded on Monday, April 10 by Jefferies. The firm has “Hold” rating given on Monday, November 2 by Nordea. BMO Capital Markets maintained it with “Buy” rating and $38.0 target in Thursday, September 14 report.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.10, from 0.98 in 2017Q2. It is negative, as 40 investors sold Canaccord Genuity Group Inc. shares while 147 reduced holdings. 62 funds opened positions while 102 raised stakes. 250.53 million shares or 1.86% less from 255.28 million shares in 2017Q2 were reported. Nomura reported 0.01% of its portfolio in Canaccord Genuity Group Inc. (TSE:CF). Macquarie Group Incorporated Ltd invested in 7,900 shares or 0% of the stock. Morgan Stanley owns 1.97M shares for 0.02% of their portfolio. Balyasny Asset Mngmt Limited Liability reported 167,048 shares or 0.02% of all its holdings. Amp Investors invested in 111,875 shares or 0.02% of the stock. Van Eck Associates holds 0.58% or 3.25 million shares. Massachusetts-based Geode Cap Mgmt Lc has invested 0.03% in Canaccord Genuity Group Inc. (TSE:CF). State Treasurer State Of Michigan holds 0.02% in Canaccord Genuity Group Inc. (TSE:CF) or 70,825 shares. Thrivent For Lutherans holds 827,920 shares. 32,563 are held by Tt. Loring Wolcott Coolidge Fiduciary Advisors Llp Ma holds 7 shares. Metropolitan Life Ins Comm Ny holds 110,743 shares. Citigroup has 0% invested in Canaccord Genuity Group Inc. (TSE:CF). Commonwealth Bank Of Australia stated it has 0.02% in Canaccord Genuity Group Inc. (TSE:CF). Shine Inv Advisory Svcs Incorporated holds 0.01% of its portfolio in Canaccord Genuity Group Inc. (TSE:CF) for 475 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: